MARKET

CLRBZ

CELLECTAR BIOSC
CLRBZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.1562
-
0.0987
-
Cellectar BioSciences Inc. published an update to their financial calendar
Reuters · 2d ago
Cellectar Biosciences Secures New Patents to Strengthen Global Cancer Drug Portfolio
Reuters · 02/17 13:05
Cellectar BioSciences Showcases Pipeline Advancements and Radiotherapeutic Platform in New Corporate Presentation
Reuters · 01/12 17:28
CELLECTAR BIOSCIENCES TO HIGHLIGHT STRATEGIC INITIATIVES FOR 2026 AT UPCOMING BIOTECH SHOWCASE DURING 44TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE
Reuters · 01/09 13:05
Director John Neis Reports Disposal of Cellectar BioSciences Inc. Common Shares
Reuters · 12/16/2025 23:00
Cellectar BioSciences Signs Multi-Year Supply Agreement with Ionetix for Alpha-Emitting Isotopes
Reuters · 12/16/2025 13:06
Cellectar BioSciences Partners with Ionetix for Alpha-Emitting Isotope Supply
Reuters · 12/16/2025 13:05
CELLECTAR BIOSCIENCES INC - ANNOUNCES MULTI-YEAR SUPPLY AGREEMENT WITH IONETIX
Reuters · 12/16/2025 13:05
More

Webull offers CELLECTAR BIOSC stock information, including NASDAQ: CLRBZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLRBZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLRBZ stock methods without spending real money on the virtual paper trading platform.